参考文献/References:
[1]冯春翠.宫颈癌患者血清TSGF、SCC含量检测及肿瘤恶性生物学行为的评估[J].海南医学院学报,2015,21(1):105-107.[2]王斌,张月桃,李琼珍.鳞癌抗原在宫颈癌前病变及早期宫颈癌治疗中的价值[J].临床和实验医学杂志,2016,28(7):677-679. [3]嵇桂娟,刘平莉,罗涛,等.初始治疗前CRP/Alb比值与小细胞肺癌患者临床病理特征及预后的关系[J].徐州医科大学学报,2019,39(7):481-486.[4]曾文新,曾红科,柳学,等.C反应蛋白与白蛋白比值在急性A型主动脉夹层手术患者预后预测中的价值[J].中华急诊医学杂志,2016,25(6):764-768.[5]周晖,卢淮武,彭永排,等.《2015年NCCN宫颈癌临床实践指南》解读[J].中国实用妇科与产科杂志,2015,26(3):185-191. [6]闫坤,胡莎莎,杨品,等.扩散峰度成像与宫颈癌病理学特征相关性的初步探索[J].磁共振成像,2016,7(9):683-688.[7]乔晓亮.血浆纤维蛋白原和鳞状细胞癌抗原在宫颈癌中的临床价值[J].安徽医药,2018,22(6):1123-1125.[8]刘琦.宫颈液基细胞学检查联合阴道镜检查在宫颈病诊断中的临床应用[J].实用中西医结合临床,2015,15(4):66-66.[9]付生弟,谢辉.肿瘤标志物CEA、CA19-9、CA72-4及CA242在胃癌诊断及预后判断中的应用价值[J].标记免疫分析与临床,2016,23(4):428-430.[10]黄兰花,李少杰,邹莹.C反应蛋白与白蛋白比值对预测慢性阻塞性肺疾病急性加重期患者预后的价值[J].国际呼吸杂志,2017,37(23):1778.[11]张瑞丽.C反应蛋白联合降钙素原检测小儿急性呼吸道感染的临床价值[J].中国药物与临床,2015,23(5):717-719.[12]沈伟,陈建华,沈俭,等.基础血清白蛋白(ALB)水平与膀胱恶性肿瘤治疗后转移的关系研究[J].实用癌症杂志,2019,31(9):1438-1440. [13]李思思,续平,陈显秋,等.术前CRP/Alb比值(CAR)和格拉斯哥预后评分(GPS)与胃癌患者临床病理参数的关系[J].临床检验杂志,2018,36(2):120-123.[14]李萍,张志斌.不同妇科疾病患者血清CA125和SCC-Ag水平分析[J].国际检验医学杂志,2014,29(21):2895-2896.
相似文献/References:
[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Medical Information,2018,31(14):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]张 洁.WBC、CRP和PCT在急诊发热患者诊治中的应用[J].医学信息,2018,31(07):157.[doi:10.3969/j.issn.1006-1959.2018.07.055]
ZHANG Jie.Application of WBC,CRP and PCT in Diagnosis and Treatment of Emergency Fever Patients[J].Medical Information,2018,31(14):157.[doi:10.3969/j.issn.1006-1959.2018.07.055]
[3]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Medical Information,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[4]蔡亚磊,邓思雨,杨 健.宫颈癌放疗增敏的研究现状[J].医学信息,2022,35(09):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
CAI Ya-lei,DENG Si-yu,YANG Jian.Research Status of Radiotherapy Sensitization for Cervical Cancer[J].Medical Information,2022,35(14):65.[doi:10.3969/j.issn.1006-1959.2022.09.016]
[5]车 莹.HPV感染与宫颈病变相关性的研究[J].医学信息,2022,35(09):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
CHE Ying.Study on the Correlation Between HPV Infection and Cervical Lesions[J].Medical Information,2022,35(14):84.[doi:10.3969/j.issn.1006-1959.2022.09.021]
[6]曹 亮,郝 朋,李阳明,等.宫颈癌所致输尿管梗阻患者输尿管支架置入成功率影响因素的Meta分析[J].医学信息,2022,35(09):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
CAO Liang,HAO Peng,LI Yang-ming,et al.Meta Analysis of Factors Influencing Success Rate of Ureteral Stent Implantation in Patients with Ureteral Obstruction Caused by Cervical Cancer[J].Medical Information,2022,35(14):124.[doi:10.3969/j.issn.1006-1959.2022.09.031]
[7]覃念群,刘 楷,米镜霖,等.基于生物信息学分析筛选与宫颈癌预后相关的关键基因[J].医学信息,2022,35(10):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
QIN Nian-qun,LIU Kai,MI Jing-lin,et al.Screening Key Genes Related to the Prognosis of Cervical Cancer Based on Bioinformatics Analysis[J].Medical Information,2022,35(14):8.[doi:10.3969/j.issn.1006-1959.2022.10.002]
[8]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Medical Information,2018,31(14):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[9]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Medical Information,2018,31(14):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[10]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Medical Information,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]